THE FIRST TREATMENT TO PREVENT AND TREAT CERVICAL LESIONS ◊ CAUSED BY THE HUMAN PAPILLOMAVIRUS
Single-dose cannulas
Patient pro le for Papilocare® Vaginal Gel
HPV+ PATIENT WITH CERVICAL LESIONS ESPECIALLY COMPLEX SITUATIONS Papilocare® Vaginal Gel HPV+ PATIENT WITH CERVICAL LESIONS
• Women over 40 • HPV persistency • Very High-Risk HPV genotype • CIN 2 in conservative management • Immunosupression • Smoker
Papilocare® Vaginal Gel + Immunocaps
◊ Low grade cervical lesions ASCUS/LSIL
Made with FlippingBook - Online magazine maker